Pancreatic Cancer Research

ResearcherUniversity of MichiganActive in the last 2 years

Benjamin Allen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-2323-8313; OpenAlex author ID A5072095842; NIH RePORTER profile ID 9342948. Sources: OpenAlex.

Their work

Papers
6 (first author 0, last author 1)
Trials
0
Grants
3
Labs led
1
Collaborators
39
Papers, trials and grants by year

2013: 1 grant · 2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 grant · 2020: 2 papers · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 grant

Papers 6

  1. Primary and metastatic cellular landscapes in human pancreatic cancer. Co-author DOI 10.1016/j.isci.2025.113012↗
  2. Combinatorial Gli activity directs immune infiltration and tumor growth in pancreatic cancer. Last author DOI 10.1371/journal.pgen.1010315↗
  3. Inhibition of Hedgehog Signaling Alters Fibroblast Composition in Pancreatic Cancer. Co-author DOI 10.1158/1078-0432.ccr-20-3715↗
  4. Differential Contribution of Pancreatic Fibroblast Subsets to the Pancreatic Cancer Stroma. Co-author DOI 10.1016/j.jcmgh.2020.05.004↗
  5. Multimodal Mapping of the Tumor and Peripheral Blood Immune Landscape in Human Pancreatic Cancer. Co-author DOI 10.1038/s43018-020-00121-4↗
  6. Dosage-dependent regulation of pancreatic cancer growth and angiogenesis by hedgehog signaling. Co-author DOI 10.1016/j.celrep.2014.09.010↗

Grants 3

  1. Investigating GLI transcription factors as regulators of the pancreatic cancer microenvironment R01CA275182↗
  2. Dosage-Dependent Hedgehog Signaling in Pancreatic Cancer R01CA198074↗
  3. Novel Hedgehog Receptors As Therapeutic Targets In Pancreatic Cancer R21CA167122↗

Closest collaborators

The 25 strongest of 39 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Marina Pasca di Magliano · 6 shared papers, 3 shared grants, 2013–2026 · strength 2.44
  2. Howard C. Crawford · 5 shared papers, 2020–2025 · strength 0.57
  3. Filip Bednar · 5 shared papers, 2020–2025 · strength 0.57
  4. Nina G. Steele · 4 shared papers, 2020–2025 · strength 0.47
  5. Samantha B. Kemp · 3 shared papers, 2020–2025 · strength 0.35
  6. Eileen S. Carpenter · 3 shared papers, 2020–2025 · strength 0.35
  7. Timothy L. Frankel · 3 shared papers, 2020–2025 · strength 0.35
  8. Valerie Gunchick · 2 shared papers, 2020–2025 · strength 0.26
  9. Katelyn L. Donahue · 2 shared papers, 2020–2025 · strength 0.26
  10. Vaibhav Sahai · 2 shared papers, 2020–2025 · strength 0.26
  11. Yaqing Zhang · 3 shared papers, 2014–2022 · strength 0.26
  12. Michael K. Scales · 2 shared papers, 2020–2022 · strength 0.22
  13. Zeribe C. Nwosu · 2 shared papers, 2021–2022 · strength 0.21
  14. Emily L. Lasse Opsahl · 1 shared paper, 2025 · strength 0.19
  15. Padma Kadiyala · 1 shared paper, 2025 · strength 0.19
  16. Ian M. Loveless · 1 shared paper, 2025 · strength 0.19
  17. Ahmed M. Elhossiny · 1 shared paper, 2025 · strength 0.19
  18. Jiaqi Shi · 1 shared paper, 2025 · strength 0.19
  19. Costas Andreas Lyssiotis · 2 shared papers, 2020–2021 · strength 0.16
  20. Rosa Elena Menjivar · 1 shared paper, 2022 · strength 0.12
  21. Daniel James Salas-Escabillas · 1 shared paper, 2022 · strength 0.12
  22. H. Carlo Maurer · 1 shared paper, 2022 · strength 0.12
  23. Kenneth P. Olive · 1 shared paper, 2022 · strength 0.12
  24. Paloma Elizabeth Garcia · 1 shared paper, 2020 · strength 0.10
  25. Yaqing Zhang · 1 shared paper, 2020 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.